101 results
Page 3 of 6
8-K
EX-99.1
0in7y
10 Dec 21
Regulation FD Disclosure
8:16am
8-K
EX-99.1
2zwux0
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
EX-99.1
gdk tbf6ey
28 Sep 21
Regulation FD Disclosure
7:30am
424B5
9ac4g8642ss ke6
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
ebmltuta17ck2143f
6 Aug 21
Entry into a Material Definitive Agreement
4:09pm
8-K
EX-10.1
602oa
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-99.1
4lptfmr9igpt4 0upczl
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-99.1
0fa27thjus0ik
4 May 21
Arvinas Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-99.1
t9kgy
1 Mar 21
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:03pm
8-K
EX-1.1
uib2yer
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
424B5
fukmx5devhbu78f
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
65o2970tlc97cy4m
14 Dec 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.2
h5j66oubuckw
14 Dec 20
Regulation FD Disclosure
7:30am
8-K
r3lbyzy7
14 Dec 20
Regulation FD Disclosure
7:30am